3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
9
Lymphoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia
6
Hematologic Neoplasms
6
Neuroblastoma
4
Neoplasms
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Lymphoid
3
Hodgkin Disease
3
Hematologic Diseases
3
Sarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Interventions
pembrolizumab
69
Nivolumab
69
cabozantinib
45
Ipilimumab
38
Specimen Handling
33
Magnetic Resonance Spectroscopy
33
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
18
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Mesna
×
1 year
×
Clear all
No trials found.